CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Keun-Sik Hong
J Stroke. 2019;21(3):259-275.   Published online September 30, 2019
DOI: https://doi.org/10.5853/jos.2019.01970

Excel Download

Non-Vitamin K Antagonist Oral Anticoagulants in Medical Conditions at High Risk of Thromboembolism beyond Atrial Fibrillation
Journal of Stroke. 2019;21(3):259-275   Crossref logo
Link1 Link2 Link3

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk
European Heart Journal. 2021;42(Supplement_1):   Crossref logo
Link1 Link2

Risk of Major Bleeding and Thromboembolism in Asian Atrial Fibrillation Patients Using Non-vitamin K Oral Anticoagulants Versus Warfarin
. 2021;   Crossref logo
Link1 Link2

Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants
Treatment of Non-vitamin K Antagonist Oral Anticoagulants. 2016;1-10   Crossref logo
Link1

P471Experience with the use of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation and a high risk of hemorrhagic complications
EP Europace. 2020;22(Supplement_1):   Crossref logo
Link1 Link2

Benefits of non–vitamin K antagonist oral anticoagulants in patients with atrial fibrillation go beyond stroke prevention
Heart Rhythm. 2017;14(4):606-607   Crossref logo
Link1 Link2

Stroke prevention in the elderly atrial fibrillation patient with comorbid conditions: focus on non-vitamin K antagonist oral anticoagulants
Clinical Interventions in Aging. 2015;1431   Crossref logo
Link1

Non-vitamin K antagonist oral anticoagulants beyond atrial fibrillation: what did we learn from COMPASS and COMMANDER-HF?
European Heart Journal. 2019;40(46):3754-3756   Crossref logo
Link1 Link2

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation at high risk of bleeding and normal kidney function
Thrombosis Research. 2017;150:123-130   Crossref logo
Link1 Link2

Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
European Heart Journal Supplements. 2020;22(Supplement_I):I32-I37   Crossref logo
Link1 Link2